Individualized Hormone Replacement Therapy Versus Ovarian Transplantation
Journal Title: World Journal of Gynecology & Womens Health (WJGWH) - Year 2019, Vol 1, Issue 5
Abstract
Numerous studies conclude that risks and benefits of hormonal replacement therapy (HRT) are dose-dependent [1]. The pharmaceutical industry attempted to partially resolve the issue of individualization of HRT by manufacturing at least six different types of Minivelle patches (0.024mg, 0.0375mg, 0.05mg, 0.075mg, and 0.1mg). The choices offered by the pharmaceuticals are useful but fail to caliber dose based on the needs of the individual patient.Each woman and her physician must decide whether ERT is an appropriate option for her. When making this decision, it is important to consider three factors that affect the risk-benefits of ERT: age at initiation, hormone dose, and route of administration [1]. Estrogen deficiency over a period of many years may result in significant, changes such as bone loss, vaginal and bladder atrophy, and/or other symptoms [1,2]. Therefore, the earlier after menopause ERT is initiated, the better the long-term outcome [1].
Authors and Affiliations
Petrikovsky BM
Trophoblastic Disease During the Third Trimester of Pregnancy: Ultrasonic Diagnostic, Clinical Case and Perinatal Outcomes
Trophoblastic disease (TFD) considers rare tumors arising preferentially in reproductive age women. TFD is a relatively rare pathology and occurs at a rate of 1 in 22000 to 1 in 100...
Therapeutic Role of Dance in the Treatment of Endometriosis-Related Chronic Pelvic Pain: A Proof-of-Concept Study
Background: Endometriosis causes chronic pelvic pain in many of the women affected, which may not remit after surgery or pharmacological treatment. Physical exercise as complementary therapy has already shown to be benef...
Uterine Rupture and Associated Factors During Labor Amongst Women Delivered in Saudi Hajjah Hospital in Hajjah City North West Yemen
Background: Uterine rupture lead to elevated maternal and neonatal mortality in a lot of rural places in the world, while in Yemen in both rural and urban places. This study was conducted...
Assisted Reproductive Technology: Where did the Journey Begin, and where are we Today – A 40-year History
Over the last four decades, significant developments have occurred within the field of assisted reproduction, initially sparked by the birth of Louise Brown in 1978, who will be forever be known as the first human...
The Mechanism of Single Progesterone as Add-Back Therapy to GnRH-a Administration
Endometriosis (EMS) is a common estrogen-dependent gynecological disorder, which affects quality of life and fertility of productive-aged women [1]. Current treatment of EMS is mainly...